Validation of new medication use algorithms as proxies for worsening disease activity in patients with juvenile idiopathic arthritis.

Kyoko SaitoAvinash GabbetaEvan MulvihillLina Al-JaberiTimothy BeukelmanJames D LewisCarlos D RoseBrian L StromDaniel B Horton

Published in: Pharmacoepidemiology and drug safety (2024)

An algorithm for new JIA medication use appears to be a reasonable proxy for worsening JIA disease activity, particularly when specifying new use ≥1 year since initiating a prior JIA medication. This algorithm will be valuable for conducting research on JIA populations within administrative claims databases.

Keyphrases

juvenile idiopathic arthritis
disease activity
systemic lupus erythematosus
rheumatoid arthritis
machine learning
rheumatoid arthritis patients
ankylosing spondylitis
deep learning
healthcare
big data
artificial intelligence
neural network